Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/OCF ratio high or low?
The Price/OCF ratio of 1.13 is 77% below its estimated 1-year average of 4.90, near the low end of its estimated 1-year range (1.13–5.51).
As of 2026-10-06T12:51:29.019Z.
Calculation as of: 2026-10-06T12:51:29.019Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f5b5977bdf8e8744ccf3bd9773e74661520241b62ab886de63a55e038e5fa23
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
1.13
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.96
median of 161 covered companies
CURRENT VS SECTOR MEDIAN
-92.92%
vs the sector median at left
Market Cap
$134.74M
Price/OCF Ratio
105.51
TTM Avg
51.49
3Y Avg
30.98
5Y Avg
26.48
Market Cap
$152.16M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$152.45M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$153.84M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIOP) | $142.49M | 1.13 | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | N/A | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $146.66M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $149.51M | N/A | 32.64 | 32.64 | 32.64 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | 105.51 | 51.49 | 30.98 | 26.48 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | N/A | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $130.05M | 4.61 | 39.51 | 39.66 | 39.66 |
P/OCF Ratio
1.1
P/FCF Ratio
1.1
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2026-10-05 | 5.32 |
| 2026-10-02 | 4.96 |
| 2026-10-01 | 4.72 |
| 2026-09-30 | 4.85 |
| 2026-09-29 | 4.90 |
| 2026-09-28 | 4.86 |
| 2026-09-25 | 4.89 |
| 2026-09-24 | 4.95 |
| 2026-09-23 | 5.01 |
| 2026-09-22 | 5.04 |
| 2026-09-21 | 5.08 |
| 2026-09-18 | 5.23 |
| 2026-09-17 | 5.26 |
| 2026-09-16 | 5.32 |
| 2026-09-15 | 5.35 |
| 2026-09-14 | 5.42 |
| 2026-09-11 | 5.42 |
| 2026-09-10 | 5.46 |
| 2026-09-09 | 5.46 |
| 2026-09-08 | 5.48 |
| 2026-09-04 | 5.51 |
| 2026-09-03 | 5.46 |
| 2026-09-02 | 5.50 |
| 2026-09-01 | 5.44 |
| 2026-08-31 | 5.51 |
| 2026-08-28 | 5.47 |
| 2026-08-27 | 5.46 |
| 2026-08-26 | 5.41 |
| 2026-08-25 | 5.38 |
| 2026-08-24 | 5.41 |
| 2026-08-21 | 5.38 |
| 2026-08-20 | 5.37 |
| 2026-08-19 | 5.35 |
| 2026-08-18 | 5.36 |
| 2026-08-17 | 5.33 |
| 2026-08-14 | 5.48 |
| 2026-08-13 | 4.66 |
| 2026-08-12 | 4.70 |
| 2026-08-11 | 4.78 |
| 2026-08-10 | 4.73 |
| 2026-08-07 | 4.84 |
| 2026-08-06 | 4.86 |
| 2026-08-05 | 4.67 |
| 2026-08-04 | 4.61 |
| 2026-08-03 | 4.63 |
| 2026-07-31 | 4.60 |
| 2026-07-30 | 4.58 |
| 2026-07-29 | 4.58 |
| 2026-07-28 | 4.57 |
| 2026-07-27 | 4.58 |
| 2026-07-24 | 4.60 |
| 2026-07-23 | 4.59 |
| 2026-07-22 | 4.61 |
| 2026-07-21 | 4.58 |
| 2026-07-20 | 4.57 |
| 2026-07-17 | 4.56 |
| 2026-07-16 | 4.53 |
| 2026-07-15 | 4.59 |
| 2026-07-14 | 4.57 |
| 2026-07-13 | 4.56 |
| 2026-07-10 | 4.52 |
| 2026-07-09 | 4.58 |
| 2026-07-08 | 4.65 |
| 2026-07-07 | 4.85 |
| 2026-07-06 | 4.93 |
| 2026-07-02 | 4.97 |
| 2026-07-01 | 4.93 |
| 2026-06-30 | 4.90 |
| 2026-06-29 | 4.89 |
| 2026-06-26 | 4.89 |
| 2026-06-25 | 4.92 |
| 2026-06-24 | 4.91 |
| 2026-06-23 | 4.88 |
| 2026-06-22 | 4.85 |
| 2026-06-18 | 4.89 |
| 2026-06-17 | 5.00 |
| 2026-06-16 | 4.93 |
| 2026-06-15 | 5.09 |
| 2026-06-12 | 5.05 |
| 2026-06-11 | 5.00 |
| 2026-06-10 | 4.90 |
| 2026-06-09 | 4.92 |
| 2026-06-08 | 4.92 |
| 2026-06-05 | 5.04 |
| 2026-06-04 | 5.14 |
| 2026-06-03 | 5.06 |
| 2026-06-02 | 4.98 |
| 2026-06-01 | 4.99 |
| 2026-05-29 | 4.74 |
| 2026-05-28 | 4.73 |
| 2026-05-27 | 4.62 |
| 2026-05-26 | 4.44 |
| 2026-05-22 | 4.07 |
| 2026-05-21 | 3.97 |
| 2026-05-20 | 3.96 |
| 2026-05-19 | 3.92 |
| 2026-05-18 | 3.92 |
| 2026-05-15 | 3.66 |
